GlassScriptPhysician profile
Cindy Haslam
NPI 1710401229
$1,459.63
in general payments reported to CMS, 2019-2025
18 companies · $559 in 2025
The $559 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $131 · 2023: $235 · 2024: $535 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,328.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $278.09 | 2023-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Sanofi Pasteur INC. | $218.28 | 2023-2025 | |
| Exact Sciences Corporation | $210.89 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $141.86 | 2022-2025 | Ozempic |
| Lexicon Pharmaceuticals, INC. | $125.00 | 2024 | Inpefa |
| Astrazeneca Pharmaceuticals LP | $110.14 | 2022 | |
| Merck Sharp & Dohme LLC | $100.29 | 2023-2025 | Rotateq, Vaxneuvance, Gardasil 9 |
| Regeneron Healthcare Solutions, INC. | $47.82 | 2023-2024 | Dupixent |
| Merz North America, INC. | $31.52 | 2025 | |
| Alnylam Pharmaceuticals INC. | $29.56 | 2023 | Givlaari |
| Bayer Healthcare Pharmaceuticals INC. | $25.24 | 2025 | |
| Lilly USA, LLC | $25.00 | 2024 | Mounjaro |
| Radius Health, INC. | $24.59 | 2023 | Tymlos |
| Cranial Technologies, INC | $20.45 | 2024 | Doc Band |
| Alk-Abello, INC | $18.86 | 2024 | Odactra, Ragwitek, Grastek |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $18.08 | 2023 | Immunocap |
| Kowa Pharmaceuticals America, INC. | $17.13 | 2025 | Zoryve |
| Leo Pharma INC. | $16.83 | 2023 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Haslam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.